ReviewThe oncologist2026

KRAS-driven immune exclusion in pancreatic ductal adenocarcinoma: mechanisms and therapeutic reversal.

Kenneth A KernPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.